CD2

CD2 Overview

English NameT-cell surface antigen CD2Approved Drugs0
Drugs in Clinical Trials3Target SynonymT11,T-Cell Surface Antigen CD2,LFA-2,CD2 Antigens,CD2,LFA-3 Receptor,CD2 Molecule,Rosette Receptor,SRBC,CD2 Antigen,CD2 Antigen (P50), Sheep Red Blood Cell Receptor,T-Cell Surface Antigen T11/Leu-5,Lymphocyte-Function Antigen-2,Erythrocyte Receptor
Highest Development StagePhase 2 Clinical
English NameT-cell surface antigen CD2
Target SynonymT11,T-Cell Surface Antigen CD2,LFA-2,CD2 Antigens,CD2,LFA-3 Receptor,CD2 Molecule,Rosette Receptor,SRBC,CD2 Antigen,CD2 Antigen (P50), Sheep Red Blood Cell Receptor,T-Cell Surface Antigen T11/Leu-5,Lymphocyte-Function Antigen-2,Erythrocyte Receptor
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 2 Clinical

CD2 Synonyms

CD2,SRBC,LFA-2,T11

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SiplizumabMEDI-507; TCD-601Phase 2 ClinicalCatholic University Of Louvain, Itb-Med LlcAmyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Cholangitis, Sclerosing; Diabetes Mellitus, Type 1; End Stage Liver Disease; Graft vs Host Disease; Hepatitis, Autoimmune; Hidradenitis Suppurativa; Kidney Diseases; Kidney Failure, Chronic; Leukemia; Liver Cirrhosis; Liver Diseases; Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Plaque psoriasis; Psoriasis; Rejection of renal transplantation; Rejection of liver transplantation; Renal Insufficiency
Details
SBT-11-5301SBT115301Phase 1 ClinicalSonoma Biotherapeutics IncAutoimmune Diseases
Details
PIT-565PIT-565Phase 1 ClinicalNovartis Pharma AgArthritis, Rheumatoid; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Neoplasms; Nephrosis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Details
  • Overview
  • Product List
  • Clinical Drug Information